Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
Cell Communication and Signaling : CCS
|
May 7, 2026
Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib - novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled
Neha Agrawal, Mythreyi Narasimhan, Rahul Mojidra, et al.
Blood Cell Therapy
|
December 26, 2023
Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant
Komal Kumbhalwar, Sachin Punatar, Anant Gokarn, et al.
The Indian Journal of Medical Research
|
November 24, 2017
Study of stem cell homing & self-renewal marker gene profile of <i>ex vivo</i> expanded human CD34<sup>+</sup> cells manipulated with a mixture of cytokines & stromal cell-derived factor 1
Jyoti Kode, Navin Khattry, Ashish Bakshi, et al.
Journal of Cancer Research and Therapeutics
|
September 11, 2018
Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors
Alok Gupta, Anant Gokarn, Deepan Rajamanickam, et al.
Oncology Research
|
February 16, 2020
miRNA-mRNA Profiling Reveals Prognostic Impact of <i>SMC1A</i> Expression in Acute Myeloid Leukemia
Nikhil Gadewal, Rohit Kumar, Swapnil Aher, et al.
American Journal of Blood Research
|
November 26, 2021
Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML)
Sachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
International Journal of Hematology
|
January 6, 2016
LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy
Navin Khattry, Alok Gupta, Reetu Jain, et al.
Cancer Biomarkers : Section a of Disease Markers
|
August 2, 2021
CD26 expression on donor harvest as a risk predictive biomarker for developing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A ten-year follow-up study
Sachin Punatar, Shruti Kandekar, Navin Khattry, et al.
American Journal of Blood Research
|
November 26, 2021
Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab
Sachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
International Immunopharmacology
|
May 17, 2020
Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT/mTOR pathway
Miten Mehta, Dievya Gohil, Navin Khattry, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
Cell Communication and Signaling : CCS
|
May 7, 2026
Reduced levels of ITGB1 cause activation of p38MAPK-ERK-LYN axis of BCR::ABL1 signaling despite inactivation of the oncoprotein by imatinib - novel resistance mechanism in blast crisis of chronic myeloid leukemia unraveled
Neha Agrawal, Mythreyi Narasimhan, Rahul Mojidra, et al.
Blood Cell Therapy
|
December 26, 2023
Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant
Komal Kumbhalwar, Sachin Punatar, Anant Gokarn, et al.
The Indian Journal of Medical Research
|
November 24, 2017
Study of stem cell homing & self-renewal marker gene profile of <i>ex vivo</i> expanded human CD34<sup>+</sup> cells manipulated with a mixture of cytokines & stromal cell-derived factor 1
Jyoti Kode, Navin Khattry, Ashish Bakshi, et al.
Journal of Cancer Research and Therapeutics
|
September 11, 2018
Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors
Alok Gupta, Anant Gokarn, Deepan Rajamanickam, et al.
Oncology Research
|
February 16, 2020
miRNA-mRNA Profiling Reveals Prognostic Impact of <i>SMC1A</i> Expression in Acute Myeloid Leukemia
Nikhil Gadewal, Rohit Kumar, Swapnil Aher, et al.
American Journal of Blood Research
|
November 26, 2021
Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML)
Sachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
International Journal of Hematology
|
January 6, 2016
LACE versus BEAM conditioning in relapsed and refractory lymphoma transplant: retrospective multicenter analysis of toxicity and efficacy
Navin Khattry, Alok Gupta, Reetu Jain, et al.
Cancer Biomarkers : Section a of Disease Markers
|
August 2, 2021
CD26 expression on donor harvest as a risk predictive biomarker for developing graft-versus-host disease post-allogeneic hematopoietic stem cell transplantation: A ten-year follow-up study
Sachin Punatar, Shruti Kandekar, Navin Khattry, et al.
American Journal of Blood Research
|
November 26, 2021
Long term outcome of a patient with relapsed refractory early thymic precursor acute lymphoblastic leukemia treated with daratumumab
Sachin Punatar, Anant Gokarn, Lingaraj Nayak, et al.
International Immunopharmacology
|
May 17, 2020
Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT/mTOR pathway
Miten Mehta, Dievya Gohil, Navin Khattry, et al.
Page
of 12